Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
HKEX:3759
Holding HK:3759?
Track your performance easily
3759 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$7.98 - HK$24.85
Previous CloseHK$16.06
Volume11.46M
Average Volume (3M)11.36M
Market Cap
HK$54.02B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.6
Beta2.01
Next Earnings
Mar 31, 2025EPS Estimate
HK$0.36Last Dividend Ex-Date
Jun 27, 2024Dividend Yield1.35%
Share Statistics
EPS (TTM)1.14
Shares Outstanding1,786,835,938
10 Day Avg. Volume12,105,607
30 Day Avg. Volume11,359,690
Standard Deviation0.20
R-Squared0.44
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)3.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$22.13Price Target Upside37.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Pharmaron Beijing Co., Ltd. Class H News
PremiumCompany Announcements
Pharmaron Beijing’s 2024 Q3 Financial Report Unveiled
PremiumCompany Announcements
Pharmaron Beijing Schedules Financial Review MeetingPremiumCompany Announcements
Pharmaron Beijing Shareholders Approve Auditors
PremiumCompany Announcements
Pharmaron Beijing: Profit Up, Dividend Hold
PremiumCompany Announcements
Pharmaron Beijing Announces EGM for Auditor Engagements
PremiumCompany Announcements
Pharmaron Beijing Sets EGM Shareholder Record DatePremiumCompany Announcements
Pharmaron Beijing Announces Upcoming Board MeetingOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.29% Mutual Funds
― Other Institutional Investors
95.06% Public Companies and
Individual Investors
3759 FAQ
What was Pharmaron Beijing Co., Ltd. Class H’s price range in the past 12 months?
Pharmaron Beijing Co., Ltd. Class H lowest stock price was HK$7.98 and its highest was HK$24.85 in the past 12 months.
What is Pharmaron Beijing Co., Ltd. Class H’s market cap?
Currently, no data Available
When is Pharmaron Beijing Co., Ltd. Class H’s upcoming earnings report date?
Pharmaron Beijing Co., Ltd. Class H’s upcoming earnings report date is Mar 31, 2025 which is in 141 days.
How were Pharmaron Beijing Co., Ltd. Class H’s earnings last quarter?
Pharmaron Beijing Co., Ltd. Class H released its earnings results on Oct 29, 2024. The company reported HK$0.19 earnings per share for the quarter, missing the consensus estimate of HK$0.248 by -HK$0.058.
Is Pharmaron Beijing Co., Ltd. Class H overvalued?
According to Wall Street analysts Pharmaron Beijing Co., Ltd. Class H’s price is currently Undervalued.
Does Pharmaron Beijing Co., Ltd. Class H pay dividends?
Pharmaron Beijing Co., Ltd. Class H pays a Annually dividend of HK$0.21 which represents an annual dividend yield of 1.35%. See more information on Pharmaron Beijing Co., Ltd. Class H dividends here
What is Pharmaron Beijing Co., Ltd. Class H’s EPS estimate?
Pharmaron Beijing Co., Ltd. Class H’s EPS estimate is HK$0.36.
How many shares outstanding does Pharmaron Beijing Co., Ltd. Class H have?
Pharmaron Beijing Co., Ltd. Class H has 301,537,140 shares outstanding.
What happened to Pharmaron Beijing Co., Ltd. Class H’s price movement after its last earnings report?
Pharmaron Beijing Co., Ltd. Class H reported an EPS of HK$0.19 in its last earnings report, missing expectations of HK$0.248. Following the earnings report the stock price went down -3.654%.
Which hedge fund is a major shareholder of Pharmaron Beijing Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3759
---
Pharmaron Beijing Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
14.98%
Trailing 12-Months
Asset Growth
3.57%
Trailing 12-Months
Company Description
Pharmaron Beijing Co., Ltd. Class H
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and others. The company generates maximum revenue from Laboratory services segment.
---
3759 Stock 12 Month Forecast
Average Price Target
HK$22.13
▲(37.80% Upside)
Technical Analysis
Best Analysts Covering 3759
1 Year
---